Cargando…

Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation

PURPOSE: Nationwide mass vaccination against Covid-19 started in Israel in late 2020. Soon we identified on [(18)F]FDG PET-CT studies vaccine-associated hypermetabolic lymphadenopathy (VAHL) in axillary or supraclavicular lymph nodes (ASLN) ipsilateral to the vaccination site. Sometimes, differentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Dan, Krauthammer, Shir Hazut, Wolf, Ido, Even-Sapir, Einat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003894/ https://www.ncbi.nlm.nih.gov/pubmed/33774684 http://dx.doi.org/10.1007/s00259-021-05314-2

Ejemplares similares

A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [(18)F]FDG PET-CT studies performed in oncologic patients
por: Cohen, Dan, et al.
Publicado: (2021)

Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy
por: Cohen, Dan, et al.
Publicado: (2021)

Is There a Role for [(18)F]FDG PET-CT in Staging MALT Lymphoma?
por: Cohen, Dan, et al.
Publicado: (2022)

Beyond Visual Assessment of Basal Ganglia Uptake: Can Automated Method and Pineal Body Uptake Assessment Improve Identification of Nigrostriatal Dysfunction on (18)F-DOPA PET/CT?
por: Hazut Krauthammer, Shir, et al.
Publicado: (2023)

Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy
por: Thaweerat, Wajana
Publicado: (2022)

Head-to-head comparison of [(68)Ga]Ga-FAPI-04 and [(18)F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma
por: Kuten, Jonathan, et al.
Publicado: (2021)

Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an (18)F-FDG PET/CT after COVID-19 Vaccination
por: Antwi, Kwadwo, et al.
Publicado: (2022)

Hypermetabolic Hurthle Cell Adenoma on (18)F-FDG PET/CT
por: Hassan, Aamna, et al.
Publicado: (2018)

Role of [18F] FDG PET-CT in detection of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) in lymphoma patients: with serologic testing correlation
por: El Sammak, Dena Abd El Aziz, et al.
Publicado: (2023)

Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
por: Felices-Farias, Jose Manuel, et al.
Publicado: (2022)

Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
por: Felices-Farias, Jose Manuel, et al.
Publicado: (2022)

Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine
por: Roca, B, et al.
Publicado: (2021)

Unusual Delayed FDG-PET/CT Hypermetabolism Due to Charcoal-Induced Granuloma
por: Rahier, Quentin, et al.
Publicado: (2018)

Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes
por: Karavani, Gilad, et al.
Publicado: (2022)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
por: Rubinski, Anna, et al.
Publicado: (2020)

Isolated cerebellar hypermetabolism on FDG PET in a case of remitted primary breast lymphoma
por: Reddy, Arun Kumar, et al.
Publicado: (2014)

Lymphadenopathy after BNT162b2 Covid-19 Vaccine: Preliminary Ultrasound Findings
por: Granata, Vincenza, et al.
Publicado: (2021)

A case of central pontine and extrapontine myelinolysis with early hypermetabolism on 18FDG-PET scan.
por: Roh, J. K., et al.
Publicado: (1998)

The Day after Mass COVID-19 Vaccination: Higher Hypermetabolic Lymphadenopathy Detection on PET/CT and Impact on Oncologic Patients Management
por: Ferrari, Cristina, et al.
Publicado: (2021)

Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on (18)F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine
por: Chiang, Meng-Ting, et al.
Publicado: (2023)

Aortic (18)F-FDG PET/CT hypermetabolism in patients with long COVID: a retrospective study
por: Dudouet, Pierre, et al.
Publicado: (2021)

[(18)F]FES PET Resolves the Diagnostic Dilemma of COVID-19-Vaccine-Associated Hypermetabolic Lymphadenopathy in ER-Positive Breast Cancer
por: Nogami, Munenobu, et al.
Publicado: (2023)

Lung mass with bilateral mediastinal hypermetabolic lymphadenopathy in a chronic smoker indicative of lung cancer?
por: Ali, Asghar, et al.
Publicado: (2019)

Diagnostic value of dynamic (18)F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes
por: Sun, Yishan, et al.
Publicado: (2023)

68Ga-PSMA-11 PET/CT Follow-Up of Patients with Prostate Cancer with Bone Metastases Who Had Reduced Bone Density after Androgen Deprivation Therapy
por: Kesler, Mikhail, et al.
Publicado: (2021)

Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT
por: Smith, Mathew V., et al.
Publicado: (2021)

Prostatic Adenocarcinoma Masquerading as Generalized lymphadenopathy and Mimicking lymphoma on FDG PET/CT: Diagnosis, Staging, and Evaluation of Therapy Response by FDG PET/CT
por: Joshi, Prathamesh, et al.
Publicado: (2012)

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
por: Waissengrin, Barliz, et al.
Publicado: (2021)

The Effects of CoronaVac (Sinovac) and BNT162b2 (BioNTech/Pfizer) Vaccination on Oncologic (18)F-FDG PET/CT Studies
por: Şan, Hüseyin, et al.
Publicado: (2022)

FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease
por: Matthews, Dawn C., et al.
Publicado: (2018)

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
por: Ligumsky, Hagai, et al.
Publicado: (2022)

Sperm quality is not affected by the BNT162b2 mRNA SARS-CoV-2 vaccine: results of a 6–14 months follow-up
por: Karavani, Gilad, et al.
Publicado: (2022)

Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report
por: Tripathy, Shreya, et al.
Publicado: (2022)

Clinically Occult Pituitary Adenoma Can Appear as a Hypermetabolic Lesion on Whole Body FDG PET Imaging in a Patient with Lymphoma
por: Karapolat, İnanç, et al.
Publicado: (2013)

Pre-Processing Method for Contouring the Uptake Levels of [18F] FDG for Enhanced Specificity of PET Imaging of Solitary Hypermetabolic Pulmonary Nodules
por: Szumowski, Piotr, et al.
Publicado: (2021)

The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological Findings
por: Lubezky, Nir, et al.
Publicado: (2007)

SUBCLINICAL LYMPHADENOPATHY ON FDG-PET IN LUNG CANCER SCREENING AFTER COVID-19 VACCINE BOOSTER
por: NGUYEN, ANH, et al.
Publicado: (2022)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022)

Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID‐19 vaccination: A mimicker of disease progression in Hodgkin lymphoma
por: Suleman, Adam, et al.
Publicado: (2021)

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients
por: Ligumsky, Hagai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3af1jdeha6fmvj0gibkp5i1oo5